This company has been acquired
NHKF.F Stock Overview
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Nichi-Iko Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.36 |
52 Week High | US$4.60 |
52 Week Low | US$0.35 |
Beta | -0.66 |
11 Month Change | 2.57% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -98.68% |
Recent News & Updates
Recent updates
Shareholder Returns
NHKF.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 3.4% | 1.6% |
1Y | n/a | 14.2% | 32.3% |
Return vs Industry: Insufficient data to determine how NHKF.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how NHKF.F performed against the US Market.
Price Volatility
NHKF.F volatility | |
---|---|
NHKF.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 10.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.2% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NHKF.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NHKF.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1947 | 2,656 | Shingo Iwamoto | www.nichiiko.co.jp |
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs.
Nichi-Iko Pharmaceutical Co., Ltd. Fundamentals Summary
NHKF.F fundamental statistics | |
---|---|
Market cap | US$24.64b |
Earnings (TTM) | -US$1.21b |
Revenue (TTM) | US$1.38b |
0.2x
P/S Ratio-0.2x
P/E RatioIs NHKF.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NHKF.F income statement (TTM) | |
---|---|
Revenue | JP¥182.88b |
Cost of Revenue | JP¥195.69b |
Gross Profit | -JP¥12.81b |
Other Expenses | JP¥147.63b |
Earnings | -JP¥160.44b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -227.92 |
Gross Margin | -7.01% |
Net Profit Margin | -87.73% |
Debt/Equity Ratio | -389.9% |
How did NHKF.F perform over the long term?
See historical performance and comparison